UT Health San Antonio

The new Center for Excellence in Diabetes will focus on research, clinical trials and prevention for a disease affecting about one in six people in the San Antonio area.

Chronic kidney disease with no clear cause is killing young people who do physical labor in Central America at an alarming rate. A UT Health San Antonio researcher has spent a decade looking for answers, and this summer, he'll study similar workers in San Antonio to see if clues he uncovers here can save lives there.

The same mRNA technology President Trump called a medical miracle is now under attack by his own administration, and the stakes go far beyond vaccines. TPR's Bonnie Petrie talks with two San Antonio scientists about the technology's history, its current uncertainty, and its future potential.

A new center for the study of chronic infectious diseases aims to develop treatments for illnesses like Valley fever, tuberculosis, HIV, and Long COVID that disproportionately affect South Texas communities. Led by Dr. Barbara Taylor, the center seeks to attract top researchers and serve as a hub for clinical trials and community-focused care.

This week, UT Health San Antonio plans to unveil new findings and strategies with research, treatment, and policy in fighting cancer among Latino and all populations.

Be Well Texas was awarded $256 million by the Texas Health and Human Services Commission to administer medications like Naloxone for opioid use disorder treatment services and to continue offering recovery support services.

Additional related studies reported that “higher blood cortisol levels are linked to an increased likelihood of developing the disease.” But identifying early risk factors is key for intervention.

A new study conducted by UT Health San Antonio showed that sleeping nine hours or more per night is associated with worsening cognitive performance, most especially for those with depression.

A digital tool that uses artificial intelligence to analyze speech patterns could help doctors detect dementia in patients when other signs and symptoms are not perceptible.

They said they found a new strategy that allows the body to use its own protein receptors to help the drugs enter cells more efficiently.